Stay updated with breaking news from Senza Omnia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oppenheimer lowered shares of Nevro (NYSE:NVRO – Free Report) from an outperform rating to a market perform rating in a research report released on Thursday, MarketBeat.com reports. NVRO has been the topic of several other research reports. StockNews.com raised Nevro from a sell rating to a hold rating in a research note on Wednesday, February […]
Nevro (NYSE:NVRO – Free Report) had its target price trimmed by Wells Fargo & Company from $20.00 to $17.00 in a report released on Thursday morning, Benzinga reports. They currently have an equal weight rating on the medical equipment provider’s stock. Other equities analysts also recently issued reports about the stock. JPMorgan Chase & Co. […]
Nevro (NYSE:NVRO – Get Free Report) had its price target dropped by research analysts at Robert W. Baird from $23.00 to $19.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm currently has a “neutral” rating on the medical equipment provider’s stock. Robert W. Baird’s price target indicates a […]
Nevro (NYSE:NVRO – Get Free Report) is scheduled to announce its earnings results after the market closes on Wednesday, February 21st. Analysts expect the company to announce earnings of ($0.50) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link. Nevro Price Performance Shares […]
Nevro (NYSE:NVRO – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday. Other research analysts have also issued research reports about the company. Royal Bank of Canada lowered Nevro from an “outperform” rating to a “sector […]